Preliminary Approval Of $40M Settlement Sought In Securities Fraud Class Suit
BALTIMORE — Lead plaintiffs in a securities fraud class suit filed against a COVID-19 vaccine contractor that experienced contamination issues at its Bayview, Md., manufacturing facility and several of its executives...To view the full article, register now.
Already a subscriber? Click here to view full article